HadAB-IN-1 structure
|
Common Name | HadAB-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 1097120-47-2 | Molecular Weight | 482.78 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H17BrClN3O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of HadAB-IN-1HadAB-IN-1 is a potent HadAB inhibitor. HadAB-IN-1 inhibits HadAB enzyme complexes activity with an IC50 value of 0.03 μM. HadAB-IN-1 also affects mycolic acid biosynthesis in Mycobacterium tuberculosis (Mtb). HadAB-IN-1 can be used for the research of tuberculosis (TB)[1]. |
| Name | HadAB-IN-1 |
|---|
| Description | HadAB-IN-1 is a potent HadAB inhibitor. HadAB-IN-1 inhibits HadAB enzyme complexes activity with an IC50 value of 0.03 μM. HadAB-IN-1 also affects mycolic acid biosynthesis in Mycobacterium tuberculosis (Mtb). HadAB-IN-1 can be used for the research of tuberculosis (TB)[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.03 μM (HadAB enzyme complexes); MIC50: 4.7 μM (Mtb)[1]. |
| In Vitro | HadAB-IN-1has inhibition activity for HadAB enzyme complexes with an IC50value of 0.03 μM[1]. HadAB-IN-1 can inhibit Mycobacterium tuberculosis (Mtb) with an MIC50value of 4.7 μM[1]. |
| Molecular Formula | C19H17BrClN3O3S |
|---|---|
| Molecular Weight | 482.78 |